As of 2026-06-08, the Intrinsic Value of Beyond Medical Technologies Inc (DOCT.CN) is -0.85 CAD. This DOCT.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.13 CAD, the upside of Beyond Medical Technologies Inc is -780.25%.
Based on its market price of 0.13 CAD and our intrinsic valuation, Beyond Medical Technologies Inc (DOCT.CN) is overvalued by 780.25%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.85 - -0.85 | -0.85 | -780.25% |
| P/E | 0.13 - 0.13 | 0.13 | 1.5% |
| DDM - Stable | (0.32) - (0.70) | (0.51) | -507.0% |
| DDM - Multi | (0.19) - (0.32) | (0.23) | -287.6% |
| Market Cap (mil) | 5.08 |
| Beta | 2.05 |
| Outstanding shares (mil) | 40.66 |
| Enterprise Value (mil) | 4.18 |
| Market risk premium | 5.10% |
| Cost of Equity | 13.18% |
| Cost of Debt | 5.00% |
| WACC | 13.07% |